Cloud Sovereignty: Switzerland steps back from using Amazon Web Services for its new national e-ID, as Europe debates whether “data residency” is enough when providers can still be governed by foreign laws. Climate Risk: A UN assessment warns the 1.5°C target is now only manageable, not avoidable, pushing Central Asia to prepare for worsening water stress. Glacier Hazards: Nepal’s glacier debris-flow disaster is flagged as among the most severe in decades, with scientists linking the broader trend to accelerating glacier loss. Physics Watch: Researchers report an unexplained particle interaction in a South Dakota liquid-xenon experiment that could hint at dark matter, though it’s not confirmed. Swiss Finance IT: Swisscom modernises Finnova banking platforms with Oracle Exadata Cloud@Customer in Swiss data centres to boost scalability and resilience. Health Research: Swiss-linked ERS studies connect early-life air pollution and classroom dust bacteria with reduced lung function and higher COPD risk. Materials for Recycling: Empa and Elantas develop a phosphorus-enabled epoxy composite that can soften or break apart under the right conditions, aiming to make composites easier to recycle.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Swiss Materials Breakthrough: Empa and Elantas developed a phosphorus-added epoxy composite that can soften or break apart under the right conditions, aiming to make flame-retardant aircraft and cabin materials easier to recycle. Geothermal Cautionary Tale: South Korea’s enhanced geothermal project hit a fault with a magnitude-5.5 quake, shutting down after damage and injuries—another reminder that deep drilling can trigger long-lasting seismic risk. Health in Schools: Swiss-linked research presented at ERS links classroom dust bacteria (including Streptomyces and Mycobacterium) to reduced lung function growth in children, pointing to better indoor air management. Swiss Tech for Disaster Response: Switzerland’s Flyability donated a tunnel-capable drone to Nepal for search-and-rescue inside hydropower project tunnels after the Bhotekoshi flood. Swiss Science & Heritage: Geneva opened the Saint-Antoine archaeological site under the Théodelinde Esplanade, revealing remains spanning two millennia. AI & Industry: Swiss Re says data centres are becoming strategic “physical economy” infrastructure, boosting insurance demand as AI capex accelerates.
Alzheimer’s Prevention Trial (Roche): Roche’s Swiss-developed trontinemab is set to be tested in a Europe-first NHS-led study for people without symptoms but at high risk, using blood tests for the p-tau217 marker and enrolling about 1,600 adults across UK sites and beyond. CERN IT Migration (Switzerland): CERN engineers in Winterthur plan to move more than 2,200 specialized computers from Red Hat Enterprise Linux to Debian to keep older hardware usable for future particle-physics runs. Swiss Drone Aid (Nepal): Switzerland provided Nepal’s rescue teams with a Flyability “Flyability” tunnel-capable drone to improve search-and-rescue and inspection in hazardous hydropower tunnels. Biotech Deal Watch (Novartis): Novartis’ $2B+ acquisition of London-based Myricx is drawing attention from Australian biotech investors as the sector faces a looming patent cliff. Space Safety: A new look at satellite crowding highlights rising orbital collision risks as the number of objects in Earth’s orbit keeps climbing.
Swiss Climate & Water Resilience: Switzerland-backed climate author Mridula Ramesh used her Himalayan Echoes speech to argue that nature’s “protective walls” are being dismantled just as disasters hit hardest. Medical Research in Switzerland: Roche’s Trontinemab is set for a “world first” prevention trial in the UK using a blood test for p-tau217, while Zurich researchers helped develop the BioTAK scoring system to flag Takotsubo (“broken heart”) before catheterization. Gene Therapy Manufacturing: NewBiologix (Switzerland) and Synastra (Turkey) will build a stable producer cell line for a Duchenne rAAV program, aiming for scalable, reproducible production. AI & Science: NVIDIA says its Nemotron-3-Ultra-CC outscored the top human at IOI 2026, underscoring both AI progress and limits. Swiss Industry & Risk: Swiss Re warns a capex “super-cycle” from data centres and energy infrastructure could drive major P&C premiums. Environment & Tourism: Valais rejected an appeal over the Rhône Glacier ice cave, keeping the controversial tourist site under pressure amid microplastic concerns.
Ig Nobel in Zurich: Quirky science awards went to studies including cockroach milk, nose-blowing, and even soil health tests using underwear—held outside the U.S. for visa reasons. Glacier protection in Switzerland: Researchers on the Tsanfleuron Glacier tested biodegradable sheep-wool sheets as a plastic-free alternative to synthetic covers, with early results suggesting similar heat protection. Heart-drug setback for Novartis: Pelacarsen lowered lipoprotein(a) but failed to cut major heart attacks and strokes in a late-stage trial, a blow to Novartis’ cardiovascular pipeline. Climate risk spotlight: Scientists warn that as glaciers melt, cascading hazards multiply, and preparedness is lagging. AI and the maritime industry: A commentary argues AI can be a “tailwind” for ship operations, but only if companies adopt it properly rather than blindly. Space tech snag: NASA confirmed a Deorbit-as-a-Service capture attempt failed on Katalyst’s LINK spacecraft, underscoring reliability and interface gaps. Swiss education tie-up (Ohio): A “Switzerland of Ohio” school district partnership expands pathways to college credit in career-technical programs.
CERN & AI: A UChicago-led team is using AI to help CERN’s Large Hadron Collider decide which collision data to keep, aiming for faster, smarter selection under real machine limits. Swiss climate tech: A new ZHAW Zurich University of Applied Sciences report says Switzerland’s ground-mounted solar is still tiny, and agri-PV remains near zero—raising questions about whether PV targets can be met without more open-field installations. Cybersecurity (Basel): Novocure, a Baar-based company, says a cybersecurity incident exposed internal patient ID numbers and limited patient/employee contact details, with no device or operations compromise. Biotech (rare disease): Ionis’ zilganersen (GFAP-targeting antisense) gets FDA commercial go-ahead for Alexander disease, adding a new pillar to rare-disease pipelines. Swiss innovation & identity: WISeKey joins the Hedera Council network to push secure authentication and digital identity, including post-quantum secured data exchange. Energy storage: Switzerland is digging a giant underground vanadium battery as grids move beyond lithium-ion. Quirky science in Zurich: The Ig Nobel Prizes return to Switzerland, with awards for cockroach milk, nose-blowing, and soil health tested via buried underwear.
Swiss Research & Space: LUX-ZEPLIN (LZ) reports its most compelling dark-matter hint yet: a single odd liquid-xenon interaction (LZ.230616) that doesn’t fit known backgrounds, though it’s not enough to claim a discovery. Swiss Pharma: Novartis says it may cut about 130 jobs in Basel as it relocates biologics lab work to its main campus, ending small-scale biologics production at Kleinbasel by end-2027 (with consultation and support measures). European Funding: The ERC handed out €705m via Starting Grants to 421 early-career researchers, with a record number of applicants and more talent planning to relocate to Europe. Swiss Economy: Switzerland’s inflation jumped to the fastest pace in nearly two years, with a weaker franc flagged as a likely driver ahead of the SNB’s next decision. Science Culture in Zurich: The Ig Nobel Prizes returned to Switzerland, awarding nose-blowing and other delightfully weird studies at a Zurich ceremony. AI & Markets (Switzerland-linked): Bank J Safra Sarasin argues the AI boom is boosting East Asia’s chip-linked exports and investment, while non-AI trade lags.
AI & Big Tech M&A: Nvidia has agreed to buy Hugging Face for $12.9B, a move that signals a push to control key open-source AI infrastructure rather than just revenue. Swiss Health Tech: GENFIT will host a virtual KOL event on Sept. 9 on non-invasive MASH diagnostics, highlighting its NIS4/NIS2+ approach as treatment options expand. Space & Astronomy: Beyond Gravity (Zurich) supplied the central computer for Europe’s Meteosat Third Generation weather satellite, while MOONS has reached “first light” at ESO’s VLT, including Swiss participation, to study the Milky Way through near-infrared spectroscopy. Climate & Resilience: The WMO warns a strong El Niño could intensify into late 2026, raising risks of extreme weather into 2027. Swiss Agriculture: Switzerland’s potato harvest hit a record low after heat, forcing imports but not creating a shortage. Robotics in Europe: AI robots demonstrated practical tasks at the European Parliament, underscoring the push for more European funding to match US/China. Defense Tech: Auterion says mass production of AI-guided drones for Ukraine has started near Munich, with Swiss ties via its Zurich engineering base.
Dark Matter Hunt: A South Dakota underground experiment reports a possible first direct interaction signal for dark matter, but scientists stress it’s a single event and not yet proof. Swiss Science & Space: ESO’s MOONS instrument has reached “first light” in Chile, with Swiss partners helping map thousands of stars and galaxies via spectra. Plant Biology for Farming: Swiss-linked plant research identifies how the AKT5 potassium channel drives leaf stalk growth, pointing to new ways to tailor crops like celery and Swiss chard. Cyber & Privacy: Swiss Re warns AI is reshaping cyber risk and highlights underinsurance gaps; separately, Proton says 85% of US-downloaded VPN apps in its sample included trackers, with many accessing GPS. Digital Identity Standards: ISO/IEC mDL and related credential standards are being made free to access in Geneva, aiming to speed adoption of digital driver’s licenses. Swiss Pharma Jobs: Novartis plans to cut up to 130 jobs in Basel by ending small-volume biologics production at Kleinbasel by 2027. Industrial Automation: ABB launches IP66/Type 4X motor drives for harsh environments, targeting food, HVACR, and water/wastewater operators.
Swiss Rare-Disease Support: Switzerland plans two new laws to boost help for people with rare diseases, including funding for specialised care structures and a national rare-disease register targeted for early 2030. Agriculture Policy Consultation: The federal government has launched a consultation on “Agricultural Policy from 2030 (AP30+)”, aiming for more food security and farmer freedom while pushing climate-adaptation measures and accountability. Glacier Protection Trial: An NGO-led experiment at Glacier 3000 in Vaud found sheep’s wool blankets can slow glacier melt similarly to synthetic tarpaulins, with a lower environmental footprint. Health Tech in Focus: Researchers in Zurich and Greifswald developed the BioTAK score to flag Takotsubo syndrome earlier—before invasive catheterization—using biomarkers and AI. Pharma Reshuffle in Basel: Novartis will cut up to 130 jobs in Basel by end-2027 as small-scale biologics production in Kleinbasel winds down and work shifts to its Rhine campus. AI & Medicine Dealmaking: Novartis also signed a deal worth up to $3.2B with Alteogen for subcutaneous drug delivery technology. Climate Risk & Research: CERN opened a Quantum Sensing Institute aimed at dark-matter searches, while a South Dakota underground experiment reported a “compelling hint” (not a discovery) of dark matter.
Swiss biotech deal: Samsung Biologics (via its Baar, Zug subsidiary Samsung Peptide) has launched a CHF 1.46bn tender offer to acquire PolyPeptide Group, aiming to delist the Swiss CDMO after the Sept. 15–Oct. 12 acceptance window. AI security: Zurich-based xorlab secured €5m to scale sovereign email security across Europe. CERN & physics AI: University of Alabama researchers are building an AI tool to process Large Hadron Collider data faster, with CERN on the France–Switzerland border. Drug discovery compute: AdaptiveFlow, an open-source AI-informed platform for ultra-large virtual drug screening, was published in Nature Biotechnology and claims major cloud cost reductions. Healthcare tech M&A: Stryker agreed to buy Zurich-based ZuriMED to expand rotator cuff augmentation tech. Energy & infrastructure: AJA Video Systems unveiled FS8, a frame-sync processor bridging SDI and IP workflows for broadcast and proAV. Climate & risk: Swiss-linked research highlights glacier-collapse dynamics behind the Nepal–Tibet floods, underscoring rising mountain disaster threats.
Swiss Food Tech: ETH Zurich researchers report a simple “freeze-structuring” method that turns whole peas, beans and lentils into a fibrous, meat-like texture—aimed at cutting waste and keeping more of the crop’s natural value. Swiss Climate & Supply Chains: Switzerland authorized limited withdrawals from mandatory emergency protein feed reserves as Rhine/Danube low water and drought disrupt imports, with up to 20% of stock available until Feb 2027. Swiss Cyber/Privacy: ProtonMail users reported fresh access problems again this week, adding to a run of disruptions after a prior Germany data-center cooling failure. Swiss Deep Earth Science: ETH Zurich-led lab work suggests Earth’s core may store hydrogen—potentially equivalent to dozens of oceans—changing how we think about the planet’s interior. Swiss Health Research: UZH researchers describe an MS therapy that aims to stop the harmful immune attack without broadly suppressing immunity, with early trial results showing safety and promising mechanisms. Global Tech/Defense With Swiss Links: Ukraine says recovered Russian ballistic-missile parts include components traced to Switzerland and other countries, highlighting enforcement gaps in sanctions. Biotech Deal: Roche pays $75M upfront for Simcere’s preclinical trispecific B-cell antibody, with up to $1.53B in total payments. AI & Finance Workflow: A Zurich-linked report argues AI adoption in financial modelling is held back by governance and assurance gaps, driving demand for downloadable templates.
Microplastics in Lake Geneva: A new University of Lausanne and EPFL study finds ultra-fine particles are far worse than previously measured, with fragments under 100 micrometres making up most of the lake’s plastic pollution and raising health concerns. Swiss pharma safety watch: Novartis pauses autoimmune CD19 CAR-T trials after three deaths linked to severe immune complications, as Bristol Myers Squibb also halts a similar program. CERN overhaul: CERN’s accelerator complex falls silent as Long Shutdown 3 begins, setting up major upgrades for the High-Luminosity LHC on the France–Switzerland border. Swiss defence capability: Switzerland sharpens its counter-drone focus, including plans for a dedicated drone battalion and training hub to strengthen neutral defence. Swiss business & IP: Samsung is ordered to pay Swatch millions in a trademark dispute, while Swiss wealth managers urge delay to an ownership register after a hack. Travel & visas: VFS Global reports double-digit growth in Chinese Schengen visa applications in the first half, with Switzerland among popular long-haul destinations.
Swiss MedTech Funding: Zurich’s KOVE Medical raised €1.7m to develop an implantable device aimed at lowering preterm birth risk after foetal surgery, targeting First-in-Human studies. Neuroscience in Switzerland: Researchers at the University of Zurich report astrocytes can rebuild damaged adult brain tissue in mice by dividing and pushing new nuclei along long cellular arms, avoiding scar formation. Brain Health & Genetics: The Swiss-AF cohort links clonal hematopoiesis (CHIP) in atrial fibrillation patients to higher rates of silent brain lesions and faster cognitive decline. Climate & Risk in the Alps: New analysis of Nepal’s glacier-lake outburst flood records highlights big gaps in hazard dating and trigger knowledge—raising the question of whether monitoring lakes alone is enough for the next Himalayan disaster. Swiss Business & IP: Swatch won a London trademark case over Samsung’s counterfeit watch-face apps, with damages set at $11.6m. Swiss Tech & Finance: UBS’s Optimus Foundation is expanding into Brazil with $10m already invested, using a strict “impact unicorn” selection model. Defense Tech (Switzerland): Switzerland is moving toward a dedicated military drone battalion by 2028, as drone-focused training ramps up.
Swiss Workforce & Skills: A new piece asks whether the U.S. can copy Switzerland’s apprenticeship model, citing ETH Zürich research and noting Swiss youth unemployment around 2–3% alongside broad, multi-industry training. Cardiology Trial (Switzerland): ESC Congress 2026 coverage highlights a randomized noninferiority result where a TAVI-first approach matched PCI-first after one year in severe aortic stenosis patients, with Zurich’s Prof. Barbara Elisabeth Stähli involved. Climate & Mountain Risk: Multiple reports keep spotlighting Nepal’s glacier-driven disaster risk, including how ice-and-rock collapses can trigger downstream flooding and why warming makes Himalayan valleys more unstable. Swiss Tech in Space: ABB and Nüvü Camēras’ camera readout system for NASA’s Nancy Grace Roman Space Telescope is highlighted as key exoplanet tech. Carbon Markets (Switzerland-linked): A Switzerland-headquartered climate-tech firm says Article 6.2 could let Indian renewable and storage projects sell traceable carbon credits to Japan, with Switzerland mentioned among potential partners. Swiss Consumer Tech: PocketBook’s PocketBook Q e-reader (E Ink Carta 1300) is set for IFA 2026 with “mindful reading” features. Science Method (Switzerland): Researchers recruited 1,000 volunteers across Switzerland to bury 2,000 pairs of underwear to test soil health, linking faster decomposition to more biologically active soils.
Swiss Rail Solar Pilot: A Swiss start-up and TransN are testing solar panels laid between railway tracks in Buttes, with the pitch that a nationwide rollout could power up to 30% of public transport electricity. Public Health & Policy: A Swiss survey finds strong support for heatwave protections, including air conditioning in public buildings (91%) and pausing construction at 33°C (81%). Security Incident: Swiss police are hunting gunmen after a rave shooting in Aarau left one dead and five injured, with motives still unclear. Medical Research: A TAVI-first strategy was noninferior to PCI-first in severe aortic stenosis patients, while a large international study warns meningioma recurrence risk estimates can swing based on diagnosis era, WHO classification, geography, and healthcare financing. Biotech/Clinical Updates: BridgeBio presented long-term ATTR-CM results for acoramidis, including CMR findings and days alive out of hospital. AI & Food Science: A new multimodal AI model predicts umami peptides and links its predictions to specific molecular features. Space Science: NASA’s Roman Space Telescope launched to map exoplanets and the hidden universe.
Swiss Defence & Drones: Switzerland is setting up a dedicated drone battalion and a recruit training hub, aiming for a fully operational unit by 2028 and a new center of excellence to test and integrate unmanned systems. Smart Cities: Zurich has topped the IMD Smart City Index for a seventh straight year, scoring highest on health & safety, mobility, activities, opportunities and governance. Climate & Mountains: Swiss experts say glacier risk is rising, with warming and extreme weather making Alps terrain more unstable; a separate report points to Nepal’s glacier-collapse disaster as a warning sign for similar hazards. Medical Research (Switzerland-linked): A heart-attack rapid testing approach from Basel researchers showed no ED stay reduction, while EPIDAURUS found intensified antiplatelet therapy increased bleeding in atrial fibrillation patients after heart attack. Environment & Materials: ETH Zurich researchers helped develop a method to extract soil nanoplastics while preserving particles, improving how much gets measured.
Swiss Defence Modernisation: Switzerland is setting up a dedicated drone battalion and a recruit training hub, with a new unmanned-systems “center of excellence” to develop, test and integrate robotics for reconnaissance and defense by 2028. Cybersecurity & AI Threats: A broad coalition of tech and security firms warns governments and businesses to harden digital defenses fast, as AI-enabled hacking could make attacks cheaper, faster and easier to scale. AI Industry Moves (Global, Swiss-relevant): Nvidia has agreed to buy Hugging Face for about $12.9bn, a major step for open AI distribution; meanwhile Amazon will permanently close Mechanical Turk on Sept 30, 2026. Health Research: The STAREE trial suggests statins cut major cardiovascular events in healthy older adults by 30% over six years, but don’t improve disability-free survival. Cardiology Trials: ESC Congress results also show intensified antiplatelet strategies can increase bleeding in atrial fibrillation patients after heart attack. Climate & Risk: Switzerland reports its hottest and driest summer on record, while Himalayan glacier-collapse flooding highlights growing mountain disaster risk that could also threaten the Alps. Finance & Trust: Swiss wealth managers are urging delay to a planned beneficial-ownership transparency register after a Liechtenstein database hack exposed data on 31,000 entities. Energy Innovation: A Swiss rail pilot is testing solar panels between tracks to generate clean electricity for public transport.
Cybersecurity in the enterprise: ServiceNow patched four serious flaws (three critical) that could let unauthenticated attackers run code, access sensitive instance data, and tamper with records across its Now Platform and ServiceNow AI. Swiss defense & drones: Switzerland plans to build a military drone battalion by 2028, sharpening its neutral-defense posture around unmanned systems. Biotech finance: Samsung Biologics is pursuing a record 3 trillion won rights offering to fund its peptide push via a Swiss deal tied to PolyPeptide Group, after market reaction hit the share price. AI governance & risk: OpenAI, Anthropic and major companies warned about urgent AI dangers, adding pressure on regulators and operators. Climate & hazards with Swiss relevance: Nepal’s glacier-collapse floods are driving new scrutiny of cascading mountain risks; scientists point to destabilized slopes and warn similar repeat collapses may be possible. Public health: The FDA approved multiple 2026–2027 COVID-19 vaccines targeting the XFG variant, expanding options for high-risk groups ahead of fall.
Himalayan Disaster Response: Nepal-Tibet flash floods are still unfolding after a glacier/ice-rock collapse triggered a fast cascade of hazards, with Nepal’s missing count now reported at 1,924 and the EU pledging €2m in immediate aid. Swiss Defence & Drones: Switzerland says it will build a military drone battalion by 2028 and set up a drone/robotics centre to coordinate counter-drone work across departments and with private operators. Quantum Automation: QuEra reports an AI agent (Anthropic’s Claude) can recover a quantum computer’s laser system in seconds, reducing the need for on-site specialists. Gene Editing in Clinic: Cleveland Clinic shares one-year Phase 1 CRISPR-Cas9 durability data for CTX310, showing sustained LDL and triglyceride reductions with no treatment-related serious safety issues. AI Security Alarm: More than 100 major companies warn that AI-driven cyber attacks are coming and call for better tools and coordination for defenders. Swiss Research Leadership: Historian Sacha Zala is elected president of the International Council of Historical Sciences (CISH). Cyber Flaws in Enterprise AI: ServiceNow patches four ServiceNow AI Platform flaws, including multiple 10.0-rated issues exploitable by unauthenticated attackers. AI Deal Watch: Nvidia’s reported plan to acquire Hugging Face highlights the push to control key AI infrastructure. Cardiac Rehab Guidance: New ESC guidelines aim to expand and standardize cardiac rehabilitation across heart conditions.
Sign up for:
Switzerland Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.